Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis.
OBJECTIVE: To determine whether elevated levels of the angiogenic cytokine vascular endothelial growth factor (VEGF), detected on presentation to an early arthritis clinic, are associated with the development of chronic and erosive arthritis. METHODS: Concentrations of VEGF and its soluble receptor,...
Main Authors: | Ballara, S, Taylor, P, Reusch, P, Marmé, D, Feldmann, M, Maini, R, Paleolog, E |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2001
|
Similar Items
-
Insights into the pathogenesis of rheumatoid arthritis from application of anti-TNF therapy.
by: Maini, R, et al.
Published: (2000) -
Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis.
by: Maini, R, et al.
Published: (1999) -
Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis.
by: Paleolog, E, et al.
Published: (1998) -
Vascular endothelial growth factor signalling in endothelial cell survival: a role for NFkappaB.
by: Grosjean, J, et al.
Published: (2006) -
VEGF release is associated with hypoxia in inflammatory arthritis
by: Taylor, P, et al.
Published: (2001)